Although this outcome was not predicted by MGMT methylation status, it was consistent with OBSC data: our DSSs suggested that TMZ (DSS = 26) and XRad (DSS = 16) would show limited efficacy against this tumor (Figure 7A). This evidence concerns the gene MGMT and neoplasm.